Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
about
Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvementUpdate on scleroderma-associated interstitial lung diseaseSevere Acro-osteolysis in a Case of Limited Cutaneous Scleroderma.A Marked Response to Immunosuppressive Intervention for Abruptly Occurring Cardiac Complications in a Case of Juvenile Systemic Sclerosis Overlapped with Dermatomyositis.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.An overview of environmental risk factors in systemic sclerosis.Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Pathophysiological Mechanisms in Sclerosing Skin Diseases.Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?Palisaded Neutrophilic Granulomatous Dermatitis in a Patient with Systemic Sclerosis-Rheumatoid Arthritis Overlap Syndrome.Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma.Validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Singapore systemic sclerosis cohort.Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.Overlap syndromes in systemic sclerosis.
P2860
Q26995764-374E4A5A-A22F-48EC-85B6-3E7C677D29AFQ27016132-F5FDBA9E-E324-4177-9884-D3778A9EE791Q33593532-06506916-FCC0-4E1A-8360-391B34DD2EDBQ37683545-49B19177-4F6E-4576-BB18-0DF03A791D74Q38630663-3742F755-B159-4ABB-B812-DDECEF574495Q38648592-37373D57-2F56-4AEE-8251-5360F0969F96Q38888863-AA381C3F-D097-479A-8109-084B114211F3Q40491053-E3D94136-52AF-466B-A5C8-FAF6FC380F63Q41462744-0A7AA7E3-C330-4DEF-94CB-699A72F0B88FQ42065918-F414A065-1D43-4855-AF5A-8F5F08971157Q47097644-E6B1C377-36BA-4B73-B62C-5F3D3E74BECFQ47811839-0262E001-B06D-477B-BF95-447BBF98118EQ47836094-1C63CE29-A0CD-4897-8F9E-ADB88E818008Q48168794-6E2C4473-52DF-481F-AAD0-CA4690F167A4Q48566617-20CCD1AC-AA2F-4666-8590-02B980F0C84EQ49072027-C730EEA8-3369-4D22-BFE1-599502BCB161Q55689957-7310DE32-D2F6-4A61-B2A9-4DC95B6C739C
P2860
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Disease progression in systemi ...... cutaneous systemic sclerosis.
@ast
Disease progression in systemi ...... cutaneous systemic sclerosis.
@en
type
label
Disease progression in systemi ...... cutaneous systemic sclerosis.
@ast
Disease progression in systemi ...... cutaneous systemic sclerosis.
@en
prefLabel
Disease progression in systemi ...... cutaneous systemic sclerosis.
@ast
Disease progression in systemi ...... cutaneous systemic sclerosis.
@en
P2093
P2860
P1476
Disease progression in systemi ...... cutaneous systemic sclerosis.
@en
P2093
Alexander Kreuter
Christiane Pfeiffer
Claudia Guenther
Cord Sunderkoetter
Ekkehard Genth
Elisabeth Aberer
Florian Meier
Gabriele Zeidler
Gerhard Fierlbeck
Gottfried Wozel
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-204487
P407
P577
2014-01-03T00:00:00Z